Advik Capital Limited Overview
Advik Capital Limited is a New Delhi-based, BSE-listed, RBI-registered NBFC that has evolved from a dormant 1980s credit company and a brief diversification into electronics (LED signage via subsidiary Advik Optoelectronics) into a small lender and capital-markets investor. Its activities span inter-corporate loans, investment in listed and unlisted securities, and — through wholly-owned subsidiary Advikca Finvest Limited — securities dealing. Between FY2022 and FY2024 it reported large, low-margin trading turnover (₹604 cr in FY2023, ₹840 cr gross in FY2024) before restating to a lending-led revenue base of ~₹21–29 cr. Since late 2025 the company has been engulfed in governance and legal turmoil: a disputed ₹64 cr loan to Elitecon International, large provisions and quarterly losses, a hostile 23.46% shareholder suing to block its ₹100 cr rights issue, auditor qualification and resignation, and the July 2026 Enforcement Directorate arrest of promoter Vikas Garg. It is best characterised today as a distressed, governance-impaired micro-cap NBFC.
Company's own description. In its FY2025 (40th) Annual Report directors' report, the company states that it intends to keep concentrating on NBFC activities, specifically financing, inter-corporate investments and capital-market activities (Source: IIFL reproduction of Directors' Report FY2025). Its Q2 FY23 press release described it as headquartered in New Delhi and engaged primarily in financing, with the wholly owned subsidiary Advikca Finvest Limited set up to deal in capital-market instruments (Source: BSE press release, 19 Oct 2022). 2026 media releases describe it as an "emerging" NBFC focused on loans and ancillary financial services (Source: BSE media release, 8 Jan 2026; ScanX, Feb 2026). Screener's current description is that the company is primarily engaged in providing financial loans and allied services.
Reporting segments. Per aggregator classification of the latest annual report, the company operates through three segments: Securities/Share Division, Loan Division, and Others (Source: Simply Wall St).
Business model. Advik Capital earns income from three sources:
-
Interest income on loans — chiefly inter-corporate deposits and term loans to corporate borrowers. The single largest disclosed exposure is a ₹64 cr loan to Elitecon International Limited (alleged loan agreement dated 12 August 2024), now subject to recovery and insolvency proceedings (Source: ScanX, Jan 2026; BSE media release, 16 Feb 2026).
-
Gains/losses on securities — fair-value changes and trading in listed and unlisted shares, held in the parent and in Advikca Finvest Limited. This line has turned negative in recent quarters: "Other Revenue" was –₹4.23 cr on a TTM basis to December 2025 (Source: StockAnalysis), and reported revenue from operations was negative (–₹2.83 cr) in Q3 FY26 (Source: Multibagg/BSE results, Jan 2026).
-
Trading turnover (historical) — in FY2022–FY2024 the consolidated group reported very large sales at near-zero margin (FY2023 revenue ₹604.29 cr against gross profit of ₹19.9 cr), consistent with commodity or securities trading booked gross.
Revenue model mix. Pure financial-services income (interest + investment gains). No product, subscription or licensing revenue. The electronics manufacturing revenue contributed by Advik Optoelectronics ended when that subsidiary was deconsolidated on 30 September 2024 (Source: Directors' Report FY2025).
Value-chain position. A balance-sheet lender funded by equity (repeated rights issues) and borrowings (interest expense of ₹10.8 cr in FY2025 — Source: StockAnalysis), lending to mid-sized corporate borrowers and taking principal positions in equities. It does not run retail lending, branch networks of scale, or fee-based advisory businesses of any disclosed size.
Customer types / end-markets. Corporate borrowers (inter-corporate loans) and capital markets (own-book investment). Retail customer base not disclosed. All operations are in India.
Independent characterisation. Advik Capital functions less as a conventional diversified NBFC than as a promoter-linked holding and treasury vehicle. Evidence: (i) four rights issues in roughly four years used to expand the equity base from ₹4.59 cr to ₹60.85 cr paid-up capital (Screener; ANI, Jun 2026); (ii) a concentrated ₹64 cr single-borrower exposure equal to a large share of its net worth; (iii) related-party, loan and tax issues flagged in the FY2026 auditor's qualified opinion (Screener announcement summary, Aug 2026); and (iv) allegations in the Fairplan derivative suit that ₹64 cr was routed through transactions involving Elitecon International, Global Tabac Legacy and Business Bay Agencies (ANI, 25 Jun 2026 — allegations not adjudicated). The business model's credibility is currently contingent on the outcome of litigation and regulatory investigations.
Strategy
Stated strategy (FY2025 Annual Report themes). The company's stated strategy is to keep focusing on NBFC activities — financing, inter-corporate investments and capital-market activities (Directors' Report FY2025). During the 2024 rights issue, management communicated an ambition to reach Systemically Important NBFC status by 2025 (DSIJ, Sep 2024). That target has not been achieved.
Initiatives announced in the last 24 months (Oct 2024 – Oct 2026).
ESG commitments: None disclosed.
Cost programmes: None disclosed.
Medium-term financial targets / guidance: None published, apart from the lapsed Systemically Important NBFC ambition.
Products & Services
No branded consumer products, platforms or technology offerings are disclosed.
Product Portfolio
| Segment | Offering | Description | Target customer | Launch / status | Pricing | Source |
|---|---|---|---|---|---|---|
Loan Division | Inter-corporate loans / term loans | Secured and unsecured lending to companies; largest disclosed exposure ₹64 cr to Elitecon International | Mid-size corporates | Ongoing; core activity | Interest rate not publicly disclosed | ScanX; BSE media releases |
Loan Division | Loans and ancillary financial services | General NBFC credit products described in 2026 releases | Corporates/individuals (not specified) | Ongoing | — | ScanX (Feb 2026) |
Securities/Share Division | Proprietary equity investment (parent) | Investments in listed and unlisted shares | Own book | Ongoing; marked-to-market losses in FY26 | — | Company PRs; StockAnalysis |
Securities/Share Division | Advikca Finvest Limited | Dealing in shares, securities and related instruments; positioned for investment-advisory role | Own book / potential advisory clients | Incorporated 2022 | — | Letter of Offer summary |
Others / planned | Category II Alternative Investment Fund | Planned fund of up to ₹250 cr for healthcare, infrastructure and other growth sectors; intermediaries mandated | HNIs / institutional investors | Announced Nov 2023; SEBI registration/launch not found | Management fees not disclosed | BSE media release, 18 Nov 2023 |
Others (discontinued) | Electronics via Advik Optoelectronics | Escape signs, photoluminescent evacuation systems, LED and electronic LED signs, emergency lighting, safety clothing, traffic safety signs, luminaires | Commercial/industrial safety buyers | 2013 – exit Sep 2024 | — | InvestorGain/Letter of Offer |
Others (historical) | Trading turnover | High-volume, low-margin trading booked gross in FY2022–FY2024 (nature of goods not specified in retrieved sources) | Counterparties not disclosed | Largely ceased after FY2024 | — | Capital Market; StockAnalysis |
“—” = not publicly disclosed.
Financial Narrative
Basis. Consolidated, INR crore, Ind AS, FY2021–FY2025 (latest five fiscal years with complete aggregator-verified data).
Primary sources. StockAnalysis income statement (INR millions converted to crore); Anand Rathi financial results page; Business Standard/Capital Market results notes; Directors' Report FY2025.
Income statement (consolidated)
Notes: FY2022 operating revenue 7.20 vs total revenue 46.47 reflects ₹39.27 cr of "other revenue" in StockAnalysis's classification; Anand Rathi shows FY2022 net sales of ₹46.46 cr. FY2024 originally reported sales of ₹839.59 cr (Capital Market, Apr 2024) — later series restate to ₹21.28 cr total revenue. FY2025 PAT shown as ₹8.23 cr (Anand Rathi) vs ₹8.40 cr attributable (Directors' Report) — the difference is minority interest/presentation.
Share count grew roughly 13× over the period (paid-up capital ₹4.59 cr → ₹60.85 cr), so per-share earnings have been heavily diluted relative to absolute profit. TTM EPS as of mid/late 2026 is –₹0.35 to –₹0.36 (Aaj Tak, Aug 2026; Investing.com, Sep 2026).
Dividends per share. Nil in every year; dividend yield 0.00% (Screener). RBI Act Section 45-IC requires transfer of at least 20% of net profit to a statutory reserve before any dividend (Directors' Report FY2025).
Margins (calculated from table 6.1)
Anand Rathi reports FY2025 PAT margin of 28.67% on its net-sales basis — consistent with the calculation above.
Revenue CAGR FY2021–FY2025 (calculated): 47% per year on the StockAnalysis total-revenue basis (₹6.25 cr → ₹29.30 cr). This figure is not meaningful as a growth indicator because of the FY2023 trading spike and the FY2024 restatement.
EBITDA. Depreciation is negligible (₹0–0.03 cr per quarter per Equitymaster). EBITDA is therefore approximately equal to operating income before interest. Formal EBITDA disclosure: not publicly disclosed.
Balance sheet
Only FY2022–FY2024 values are disclosed (InvestorGain summary of September 2024 Letter of Offer). The DSIJ article (Sep 2024) described the company as having total assets of about ₹200 cr.
Other balance-sheet items:
FY2026 and FY2027 year-to-date (quarterly, consolidated)
Sources: Q1FY26 total income ₹7.42 cr and Q4FY26 total income –₹7.45 cr (Kotak Neo, Aug 2026); Q2FY26 sales ₹5.67 cr and net profit ₹0.59 cr (Business Standard/Capital Market, Oct 2025); Q3FY26 revenue –₹2.83 cr and net loss ₹20.87 cr, including provisions of ₹18.77 cr (BSE results via Multibagg/ScanX, Jan 2026); Q1FY27 total income ₹4.15 cr and loss ₹1.19 cr (Kotak Neo); Q2FY27 sales ₹1.90 cr and net loss ₹6.93 cr (JM Financial/Capital Market, 15 Oct 2026).
Commentary on trends, inflections and drivers
FY2021–FY2022: dormant base. Revenue of ₹6 cr and profit below ₹0.5 cr, consistent with a shell-like listed NBFC before the Garg family consolidated control between October 2021 and April 2022.
FY2023–FY2024: turnover boom. Gross sales surged to ₹604 cr (FY2023) and ₹840 cr (FY2024 as originally reported) at gross margins of 1–3%. This was a scale-up of pass-through trading, funded by rights-issue equity and rising borrowings (interest expense rose from ₹0.20 cr in FY2022 to ₹7.54 cr in FY2024). Headline profit peaked at ₹9.3 cr in FY2023.
FY2025: reported peak of lending income. Operating revenue of ₹28.7 cr (now almost entirely interest and investment income, gross margin 99%) and PAT of ₹8.2–8.4 cr. However, interest costs climbed to ₹10.8 cr, so pre-tax margin compressed to 36.5%. Q4FY25 already showed a loss (–₹1.22 cr per IndMoney).
FY2026: collapse. Negative revenue in Q3 and Q4 reflects mark-to-market losses on securities. The ₹18.77 cr provision in Q3 is most plausibly linked to the disputed Elitecon exposure (inference; not explicitly confirmed in retrieved disclosures). The FY2026 audit carried qualifications on loans, related-party transactions and tax matters (Screener announcement summary), and the auditor resigned the next day.
FY2027 to date. Income has fallen to ₹2–4 cr per quarter and losses persist, with a ₹6.93 cr loss in Q2FY27 and negative operating margin (–11.58%). The core earnings engine is impaired: the main loan is non-performing and in litigation, the equity book is losing value, and new capital-raising is enjoined by court order.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansFinancial Detail
Group Entities
| Entity | Relationship | Activity | Status | Source |
|---|---|---|---|---|
Advik Capital Limited | Parent; listed NBFC | Lending, inter-corporate investments, capital-market activities | Active | Annual Report FY2025 |
Advikca Finvest Limited | Wholly owned subsidiary (100%; nominees hold 6 shares) | Dealing in shares and securities; investment activity | Active per FY2025 report | Directors' Report FY2025; Letter of Offer |
Advik Optoelectronics Limited | Former subsidiary (57.99%) | LED signs, photoluminescent evacuation systems, emergency lighting, safety clothing, traffic signs | Ceased to be subsidiary 30 Sep 2024 | Directors' Report FY2025 |
Advik Laboratories Limited | Promoter-group "sister" company (not a subsidiary) | Pharmaceuticals; separate rights issue also enjoined | Group concern | Punekar News; News24 (Jun 2026) |
Segment Overview
| Segment | Contents | Source |
|---|---|---|
Loan Division | Inter-corporate loans, term loans; interest income | Simply Wall St (segment names) |
Securities/Share Division | Proprietary investment and dealing in equities (parent and Advikca Finvest) | Simply Wall St |
Others | Residual activities; historically trading turnover and (to Sep 2024) electronics manufacturing | Simply Wall St |
Results by Segment and Segment Assets & Liabilities
| Metric | FY2024 | FY2025 |
|---|---|---|
Standalone income from operations (INR Cr) | 16.44 | 23.07 |
Consolidated income from operations (INR Cr) | 12.92 | 28.72 |
Consolidated profit attributable to equity holders (INR Cr) | 6.47 | 8.40 |
Income Statement
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Total revenue (INR Cr, StockAnalysis basis) | 6.25 | 46.47 | 604.30 | 21.28 | 29.30 |
Operating revenue (INR Cr) | 5.77 | 7.20 | 604.30 | 12.92 | 28.72 |
Cost of revenue (INR Cr) | 4.46 | 38.57 | 584.40 | 1.19 | 0.28 |
Gross profit (INR Cr) | 1.79 | 7.90 | 19.91 | 20.09 | 29.02 |
Operating expenses (INR Cr) | 1.50 | 7.17 | 3.78 | 3.73 | 6.47 |
Operating income before interest (INR Cr) | 0.30 | 0.73 | 16.13 | 16.36 | 22.55 |
Interest expense (INR Cr) | 0.21 | 0.20 | 2.95 | 7.54 | 10.80 |
Profit before tax (INR Cr) | 0.10 | 0.63 | 12.83 | 8.98 | 10.69 |
Net profit (INR Cr) | 0.08 | 0.48 | 9.35 | 6.36 | 8.23 |
Net profit attributable to owners (INR Cr) | 0.08 | 0.48 | 9.28 | 6.47 | 8.40 |
Margin Analysis (%)
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Gross margin (%) | 28.6 | 17.0 | 3.3 | 94.4 | 99.0 |
Operating margin before interest (%) | 4.8 | 1.6 | 2.7 | 76.9 | 77.0 |
Pre-tax margin (%) | 1.6 | 1.4 | 2.1 | 42.2 | 36.5 |
Net margin (%) | 1.3 | 1.0 | 1.5 | 29.9 | 28.1 |
Balance Sheet
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Paid-up equity capital (INR Cr) | 4.59 | 4.59 | 22.02 | 42.82 | 60.85 |
Total assets (INR Cr, per Letter of Offer summary) | 0 | 16.69 | 142.56 | 204.18 | 0 |
Financial Analysis
| Item | Latest available | Source |
|---|---|---|
Book value per share | ₹2.35 (Sep–Oct 2026); ₹2.89 (early 2026, pre-loss); ₹2.62 (mid-2025); ₹1.85 (2024, pre-rights) | Screener snapshots |
Implied net worth (calculated: BVPS × 60.85 cr shares) | ≈ ₹143 cr (late 2026) | Calculated |
Goodwill & intangibles | None disclosed | — |
Working capital days (standalone) | 0.95 (FY2025), –99.82 (FY2024), –1.41 (FY2023), 22.45 (FY2022) | Screener |
Financial Analysis — Dividends paid
| Item | Disclosure status |
|---|---|
Dividends paid | Nil (FY2021–FY2025) |
Equity raised | Rights issues: Mar 2022 (19:5), Sep 2023 (17:18), Oct 2024 (14:30 at ₹2.50; up to ₹49.95 cr). Paid-up capital rose from ₹4.59 cr to ₹60.85 cr in three years |
Financial Analysis — ROE
| Ratio | Value | Period | Source |
|---|---|---|---|
ROE | 4.78% (standalone); 5.93% (consolidated); 3-year average 9.24–11.0% | FY2025 | Screener snapshots |
ROE (latest) | –14.3% | TTM to Jun 2026 | Screener (Oct 2026) |
ROCE | 8.31–8.42% (FY2025); –5.13% (latest) | FY2025; TTM | Screener |
Interest coverage | Flagged "low" by Screener; calculated FY2025 operating income/interest = 2.1× | FY2025 | Screener; calculated |
Price/Book | 0.43–0.45× | Aug–Oct 2026 | Screener; Aaj Tak |
Income Statement (Quarterly)
| Metric | Q1FY26 | Q2FY26 | Q3FY26 | Q4FY26 | Q1FY27 | Q2FY27 |
|---|---|---|---|---|---|---|
Total income / sales (INR Cr) | 7.42 | 5.67 | -2.83 | -7.45 | 4.15 | 1.90 |
Net profit (INR Cr) | 0.48 | 0.59 | -20.87 | -0.43 | -1.19 | -6.93 |
Revenue by Region
| Region | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
India revenue (INR Cr, consolidated total revenue) | 604.30 | 21.28 | 29.30 |
Outside India revenue (INR Cr) | 0 | 0 | 0 |
Change by Period
| Period | Change | As of | Source |
|---|---|---|---|
1 month | –0.76% | 25 Dec 2025 | Business Standard |
3 months | –10.88% | 25 Dec 2025 | Business Standard |
12 months | –41.26% | 25 Dec 2025 | Business Standard |
3 years | –48.43% | 25 Dec 2025 | Business Standard |
Valuation Snapshot
| Multiple | Value | Source |
|---|---|---|
P/E | Not meaningful (TTM EPS –₹0.35 to –₹0.36) | Aaj Tak; Investing.com |
P/B | 0.43–0.45× | Screener; Aaj Tak |
Sector P/E reference | ~20.5× | Aaj Tak |
Capital Markets
| Item | Detail |
|---|---|
Analyst consensus | None. MarketsMojo algorithmic rating: "Strong Sell" |
Dividend history | No dividends paid |
Corporate actions | 1:10 split (Dec 2017); rights issues Mar 2022 (19:5), Sep 2023 (17:18), Sep–Oct 2024 (14:30 at ₹2.50); proposed ₹100 cr rights (Apr 2026, enjoined) |
Credit ratings (Moody's/S&P/Fitch or domestic) | None disclosed |
Liquidity | Daily volumes typically 0.3–7 lakh shares (Aaj Tak; Investing.com; MarketsMojo) |
Analyst Conclusions
Management guidance. None issued. Management's stated priorities are protecting shareholder interests, pursuing recovery from Elitecon and completing capital raising (ScanX, Jun 2026).
Consensus. No coverage.
Bull case
-
Asset recovery. A successful NCLT/High Court outcome against Elitecon (₹71.15 cr claim) would bring in cash exceeding the current market cap (~₹62 cr) and allow write-back of the ₹18.77 cr provision.
-
Deep discount to book. At ~0.45× book (≈₹143 cr implied net worth), even partial realisation of assets yields upside if remaining assets are genuine.
-
Governance reset. A change of control — for example, Fairplan or another investor taking charge after the promoter's legal troubles — could lead to re-capitalisation under clean management.
Bear case
-
Asset quality is unverifiable. The auditor qualified the FY2026 accounts on loans and related-party issues and then resigned, so reported book value may be overstated.
-
Borrower disputes the debt. Elitecon contends the loan documents are forged, and SEBI has an interim order against Elitecon. Recovery could take years or fail.
-
Promoter risk. The promoter is in PMLA proceedings with ≈₹940.77 cr of assets attached. The listed vehicle faces contagion, possible attachment of promoter shares, and regulatory scrutiny.
Catalysts and monitorables (next 12 months)
-
Appointment of a new statutory auditor and the nature of any further qualifications.
-
Delhi High Court / NCLT orders in the Elitecon matter.
-
Outcome of the Patiala House Court derivative suit and of the injunction on the rights issue.
-
Developments in the ED/PMLA case, including bail and any attachment of promoter shareholding.
-
Any RBI action on the NBFC registration.
-
Quarterly results (Q3 FY27 due by mid-February 2027), particularly further provisioning.
-
Stock-exchange surveillance measures (ASM/GSM).
Analyst verdict
Advik Capital Limited is no longer an investment case grounded in operating fundamentals; it is a special situation dominated by legal, governance and regulatory outcomes. Between FY2022 and FY2025 the company turned a dormant 1985 shell into a functioning NBFC. It raised equity through serial rights issues, scaled trading turnover to ₹600–840 cr, and by FY2025 generated ₹8 cr of profit on ₹29 cr of high-margin lending and investment income. That progress has unravelled within twelve months.
The concentrated ₹64 cr loan to Elitecon International — roughly 40% of current implied net worth — is disputed, with the borrower alleging forgery. A ₹18.77 cr provision in Q3 FY26 drove a ₹20.87 cr quarterly loss, and losses have continued into FY2027. The equity book has produced negative revenue. The FY2026 audit was qualified on loans, related-party and tax matters, and the auditor resigned the following day. A 23.46% shareholder has obtained a court injunction freezing the ₹100 cr rights issue on a prima facie case of mismanagement. The promoter, Vikas Garg, was arrested by the Enforcement Directorate on 14 July 2026 in a high-profile money-laundering case.
The 0.45× price-to-book multiple is not a margin of safety when the auditor has declined to vouch fully for the book. Positive optionality exists — successful recovery from Elitecon or a credible change of control could re-rate the stock sharply. But both outcomes depend on slow Indian judicial processes whose results are binary and outside management's control.
Verdict: High-risk, governance-impaired micro-cap. Institutional investors should regard the shares as uninvestable until three conditions are met:
-
a new auditor issues an unqualified opinion;
-
the Elitecon claim is resolved; and
-
the promoter and control questions are settled.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansExecutive Leadership
Board of Directors
| Name | Role | Tenure / appointment | Background | Source |
|---|---|---|---|---|
Narendra Kumar Singhal | Whole-time Director (DIN 10800406); listed as CEO by aggregators | DIN series implies appointment c. 2024–2025 | — | ScanX (Apr 2026); Simply Wall St |
Vikas Garg | Promoter (former promoter-director) | Acquired control 2021–22 | Promoter of Vikas Lifecare, Vikas Ecotech, Eraaya Lifespaces; chairman of Ebix Group; arrested by ED 14 Jul 2026 | Exchange4media; TaxTMI/PTI |
Seema Garg | Promoter-director (per 2024 SEBI order) | — | Promoter family | Moneylife |
Sukriti Garg | Promoter-director (per 2024 SEBI order) | — | Promoter family | Moneylife |
Mr. | Independent Director | Appointed Oct 2025 | Over four decades in the Indian financial sector | ScanX (Oct 2025) |
Nisha Mittal | Company Secretary & Compliance Officer | — | — | ScanX |
| — | — | 2,026 | — | ScanX headline |
“—” = not publicly disclosed.
Board & Management Changes
| Date | Change | Context |
|---|---|---|
May 2025 | New Company Secretary and statutory auditors appointed | Board meeting approving FY2025 results (Screener) |
Oct 2025 | Independent Director Puniani appointed | Governance strengthening (ScanX) |
24 Jan 2026 | Committees reconstituted | Same meeting as ₹20.87 cr Q3 loss |
| 2026 | CS resignation reported | ScanX headline |
14 Jul 2026 | Promoter arrested by ED | Mahadev/SkyExchange PMLA case |
14 Aug 2026 | Internal auditor appointed; FY26 audit qualified | Screener |
15 Aug 2026 | Statutory auditor KSMC & Associates resigns | Screener |
Major Shareholders
| Holder | Stake | Date | Source |
|---|---|---|---|
Fairplan Distributors Pvt. Ltd. | 23.46% (14,27,77,126 shares) | 27 Mar 2026 | ScanX SAST disclosure |
Promoter & promoter group (Garg family) | 22.49% | Latest two quarters | Zerodha/Screener |
Public / others | ≈ 54% (calculated residual) | — | Calculated |
Institutional (MF/FII) | Nil or negligible; not disclosed as material | — | Zerodha (no MF holding cited) |
Competitive Landscape
Market Share by Competitor
| Competitor | Segment overlap | Revenue / market share | Relative positioning | Source |
|---|---|---|---|---|
Vibrant Global Capital | Investment & lending | — | Peer micro-cap | Business Standard peer list |
Gowra Leasing & Finance | Lending / leasing | — | Peer micro-cap | Business Standard |
Ramchandra Leasing & Finance | Lending | — | Peer micro-cap | Business Standard |
Mukesh Babu Financial Services | Investment, lending | — | Peer micro-cap | Business Standard |
WSFX Global Pay | Financial services (forex) | — | Adjacent | Business Standard |
Bajaj Finance, Shriram Finance, Cholamandalam | Corporate/retail lending (scale benchmark) | Far larger (₹10,000s cr) | Not real competitors; define cost-of-funds benchmark | General industry knowledge |
Recent Developments
The latter is the official arrest date per ED.



